Document Classification

Section Type: RESULTS

Text: Average daily fat intake was comparable between treatment groups within each age group (adults vs pediatric/adolescent), but placebo patients had a significant (p < 0. 001) mean decrease in coefficient of fat absorption (adult, 36. 9 percentage points ; pediatric/adolescent, 34. 9 percentage points) from open-label to double-blind treatment compared to pancrelipase patients (adult, 2 percentage points ; pediatric/adolescent, 3. 25 percentage points) ; this difference was caused by a greater (p < or = 0. 001) increase in mean fecal fat excretion (grams per day) in the placebo groups compared to pancrelipase groups (adult : 61. 9 vs 2. 3 ; pediatric/adolescent : 45. 4 vs 4. 1).